Related Experiment Video

Updated: Jun 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Teruhisa Kawamura1, Jotaro Suzuki, Yunyuan V Wang

  • 1Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, USA.

Nature
|August 12, 2009
PubMed

Insights

Scientists found that inhibiting the p53 pathway significantly boosts the efficiency of creating induced pluripotent stem (iPS) cells from somatic cells. This discovery enhances reprogramming methods and reduces cancer risks.

Area of Science:

  • Cell Biology
  • Stem Cell Research
  • Molecular Biology

Background:

  • Induced pluripotent stem (iPS) cell generation is crucial for regenerative medicine.
  • Current reprogramming methods using pluripotency factors and oncogenes suffer from low efficiency and malignant transformation risks.
  • The p53 pathway's role in limiting somatic cell reprogramming efficiency is not fully understood.

Purpose of the Study:

  • To investigate the mechanisms limiting somatic cell reprogramming efficiency.
  • To identify strategies for enhancing iPS cell generation while minimizing oncogene use and malignant transformation.
  • To explore the role of the p53 pathway in the reprogramming process.

Main Methods:

  • Investigated the activation of the p53 pathway during reprogramming.
  • Reduced p53 signaling by expressing a mutated negative regulator, deleting/knocking down p53 or p21, or antagonizing apoptosis.
  • Assessed reprogramming efficiency in mouse and human somatic cells.

Main Results:

  • Reprogramming factors activate the p53 pathway, limiting efficiency.
  • Reducing p53 signaling significantly increased reprogramming efficiency in mouse fibroblasts.
  • Decreased p53 levels allowed iPS cell generation using only Oct4 and Sox2, producing germline-transmitting chimaeric mice.
  • Silencing p53 markedly enhanced human somatic cell reprogramming efficiency.

Conclusions:

  • The p53 pathway is a key barrier to efficient somatic cell reprogramming.
  • Inhibiting p53 signaling offers a novel strategy to improve iPS cell generation efficiency.
  • This approach provides a safer and more effective method for generating iPS cells, with potential clinical applications.

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...